[Zebra in The Times of Israel] Israel’s Zebra gets FDA nod for product that detects coronary calcium

Zebra Medical Vision, an Israeli startup that uses machine learning technology to read and analyze data from CT and X-ray scans, said it has received a nod from the US Food and Drug Administration that will allow the firm to market its product in the US, to help physicians detect the buildup of calcium in coronary arteries, which serves as a measure of heart disease risk.

Read more on The Times of Israel here.